作者: D. L. Morton , D. W. Ollila , E. C. Hsueh , R. Essner , R. K. Gupta
DOI: 10.3322/CANJCLIN.49.2.101
关键词: Metastatic melanoma 、 Oncology 、 Disease 、 Treatment plan 、 Adjuvant 、 Cytoreductive surgery 、 Internal medicine 、 Tumor burden 、 Immunotherapy 、 Immune system 、 Medicine
摘要: Although patients with metastatic disease are usually not offered surgery as part of their comprehensive treatment plan, the authors suggest that surgical reduction tumor burden may enhance host immune response and create a favorable setting for use active specific immunotherapy.